Abstract:Abstract Background Wu Mei Pills (WMP) is a traditional Chinese medication that exhibits considerable anti-inflammatory effects. While WMP has been documented for its efficacy in treating RA, its mechanism of action on the condition remains unestablished. Methods The chemical composition of WMP was analyzed through UPLC-MS. Next, the enzyme-linked immunosorbent assay, cell scratch, Transwell, and Western blotting techniques were used to investigate its intrinsic mechanism. Lastly, the effect of WMP in inhibiting RA was explored by applying it to CIA rats. Result UPLC-MS analysis detected 181 compounds in WMP. RA-FLS migration and invasion mechanisms were significantly hindered by serum containing WMP (2%, 8%). Moreover, WMP (0.5 g/kg, 2 g/kg) restricted arthritis and immune organ indices in CIA rats with type II collagen-induced rheumatoid arthritis by blocking TLR4-NF-κB inflammatory pathway activation. Conclusions WMP is valuable in mitigating the course of RA through inhibiting the classical TLR4-NF-κB inflammatory pathway and reducing the secretion of inflammatory factors in the serum of RA-FLS and CIA rats. Moreover, it regulates the dynamic balance of MMP-2/TIMP-2, MMP-9/TIMP-1, modulates the mechanism of RA-FLS invasion, and safeguards articular cartilage tissues in RA.

What problem does this paper attempt to address?

### Problems the paper attempts to solve This paper aims to explore the specific mechanism by which Wu Mei Pill (WMP) inhibits rheumatoid arthritis (RA) through the TLR4 - NF - κB pathway. Specifically, the research attempts to answer the following questions: 1. **Chemical components of Wu Mei Pill and their anti - inflammatory effects**: Through UPLC - MS analysis, determine the chemical components in Wu Mei Pill and verify whether they have significant anti - inflammatory effects. 2. **Effect of Wu Mei Pill on the migration and invasion of rheumatoid arthritis fibroblast - like synoviocytes (RA - FLS)**: Through scratch assay and Transwell assay, evaluate whether Wu Mei Pill can inhibit the migration and invasion abilities of RA - FLS. 3. **Effect of Wu Mei Pill on the TLR4 - NF - κB inflammatory pathway**: Through Western blotting and other techniques, study whether Wu Mei Pill can inhibit the expressions of TLR4 and NF - κB, thereby reducing the inflammatory response. 4. **Effect of Wu Mei Pill on the collagen - induced rheumatoid arthritis (CIA) rat model**: Through animal experiments, evaluate the therapeutic effect of Wu Mei Pill on RA in vivo, including the effects on joint swelling, immune organ index, and the levels of inflammatory factors in serum. 5. **Regulatory effect of Wu Mei Pill on the MMPs/TIMPs balance**: Study whether Wu Mei Pill can regulate the balance between matrix metalloproteinases (MMPs) and tissue - type metalloproteinase inhibitors (TIMPs), thereby inhibiting the migration and invasion of RA - FLS. ### Research background Rheumatoid arthritis (RA) is a disease caused by over - active autoimmunity, manifested as joint inflammation, synovial tissue hyperplasia, and angiogenesis. Long - term RA can lead to disability and seriously affect the quality of life of patients. Although the pathological mechanism of RA has not been fully elucidated, studies have shown that pattern recognition receptors (PRRs), especially the Toll - like receptor (TLR) family, play an important role in the pathogenesis of RA. Activation of TLR4 can trigger a series of inflammatory reactions, leading to aggravated joint inflammation. In addition, the NF - κB pathway also plays a key role in the development of RA, promoting the secretion of inflammatory factors and joint damage. ### Research significance As a traditional Chinese medicine compound, Wu Mei Pill is used in traditional Chinese medicine theory to treat "Bi - syndrome" caused by external pathogenic factors such as wind, cold, and dampness, which is consistent with the etiology of RA. Although previous studies have shown that Wu Mei Pill has a significant anti - inflammatory effect, its specific mechanism is still unclear. Therefore, this study hopes to provide a theoretical basis for the development of new RA treatment methods by in - depth exploration of the mechanism by which Wu Mei Pill inhibits RA through the TLR4 - NF - κB pathway. ### Conclusion The research results show that Wu Mei Pill effectively alleviates the symptoms and joint destruction of RA by inhibiting the TLR4 - NF - κB inflammatory pathway, reducing the secretion of inflammatory factors, and regulating the balance of MMPs/TIMPs. These findings provide a scientific basis for Wu Mei Pill as a potential RA treatment drug.

Study on the mechanism of action of Wu Mei Pill in inhibiting rheumatoid arthritis through TLR4-NF-κB pathway

Elucidating the material basis and potential mechanisms of Ershiwuwei Lvxue Pill acting on rheumatoid arthritis by UPLC-Q-TOF/MS and network pharmacology

Network analysis combined with pharmacological evaluation strategy to reveal the mechanism of Tibetan medicine Wuwei Shexiang pills in treating rheumatoid arthritis

Dissecting the Molecular Mechanism of Wang-Bi Capsule in the Treatment of Experimental Rheumatoid Arthritis Based on Synovial Tissue Proteomic Analysis

Efficacy and mechanism of the Ermiao San series of formulas for rheumatoid arthritis based on Chinmedomics strategy

Mechanism of Action of Ermiao San on Rheumatoid Arthritis Based on Bioinformatics and Molecular Dynamics

Wutou decoction ameliorates experimental rheumatoid arthritis via regulating NF-kB and Nrf2: Integrating efficacy-oriented compatibility of traditional Chinese medicine

Uncovering pharmacological mechanisms of Wu-tou decoction acting on rheumatoid arthritis through systems approaches: drug-target prediction, network analysis and experimental validation

Identification of the Main Active Components and Mechanism of Wang Bi Tablet in Treating Rheumatoid Arthritis Based on Integrative Pharmacology

Exploration of the molecular mechanism guiding Xinfeng capsule regulatory mechanism for rheumatoid arthritis inflammation

Network Pharmacology-Based Analysis on the Effects and Mechanism of the Wang-Bi Capsule for Rheumatoid Arthritis and Osteoarthritis

Integrated Multi-Omics Techniques and Network Pharmacology Analysis to Explore the Material Basis and Mechanism of Simiao Pill in the Treatment of Rheumatoid Arthritis

Wutou Decoction attenuates rheumatoid arthritis in rats through SIRT1-mediated deacetylation of the HMGB1/NF-κB pathway

Water extracts of Tibetan medicine Wuweiganlu attenuates experimental arthritis via inducing macrophage polarization towards the M2 type

Integrated Experimental Approach, Phytochemistry, and Network Pharmacology to Explore the Potential Mechanisms of Cinnamomi Ramulus for Rheumatoid Arthritis

Traditional Tibetan Medicine Twenty-Five Wei’er Tea Pills Ameliorate Rheumatoid Arthritis Based on Chemical Crosstalk Between Gut Microbiota and the Host

Systems Pharmacology Dissection of Multiscale Mechanisms of Action for Herbal Medicines in Treating Rheumatoid Arthritis

Mechanism investigation of Duhuo Jisheng pill against rheumatoid arthritis based on a strategy for the integration of network pharmacology, molecular docking and in vivo experimental verification

WTD Attenuating Rheumatoid Arthritis via Suppressing Angiogenesis and Modulating the PI3K/AKT/mTOR/HIF-1α Pathway

Herbal formula Xian-Fang-Huo-Ming-Yin regulates differentiation of lymphocytes and production of pro-inflammatory cytokines in collagen-induced arthritis mice

Total Saponins of Radix Clematis Regulate Fibroblast-Like Synoviocyte Proliferation in Rheumatoid Arthritis via the LncRNA OIP5-AS1/MiR-410-3p/Wnt7b Signaling Pathway